Figure 2
Figure 2. Accelerated hematopoietic recovery in HO-1+/− mice treated with 5-FU and reconstitution in recipients of large numbers of HO-1+/− BM cells. (A) Leukocyte counts of HO-1+/− mice after myelotoxic injury. HO-1+/− or HO-1+/+ mice (n = 10) were treated with a single dose of 5-FU (150 mg/kg intraperitoneally), and leukocyte counts in the peripheral blood were performed at different time points after treatment and are shown as a mean (± SD) percentage of normal leukocyte count. (B,C) Hematopoietic engraftment from HO-1–deficient BM cells in lethally irradiated recipients. BM cells (5 × 106) from luc+HO-1+/− or luc+HO-1+/+ mice were transferred into lethally irradiated recipients (n = 4) and hematopoietic engraftment was monitored by BLI. Representative BLI images of the recipients of luc+HO-1+/− or luc+HO-1+/+ cells at day 18 are displayed at the same scale (B). Time course of hematopoietic reconstitution, as measured by whole-body bioluminescent intensity (mean ± SD, photons/s) over time (C). (D) Representative FACS plots and (E) relative trend of CFSE+Lin−Sca-1+ cell distribution versus number of cell division in vivo. Nucleated BM cells (1 × 107) from either HO-1+/− or HO-1+/+ mice were labeled by CFSE (1 μM) and transferred into lethally irradiated recipients. Cells recovered from the BM of the recipients 48 hours after transfer were pooled (3 mice/group) and costained by antibodies against lineage markers and Sca-1. The number of cell divisions and cell distribution were analyzed by CFSE intensity after gating for the Lin−Sca-1+ population. Values are absolute (D) or relative (E) mean percentages (n = 4) of cells undergoing different numbers of cell divisions from 2 different experiments.

Accelerated hematopoietic recovery in HO-1+/− mice treated with 5-FU and reconstitution in recipients of large numbers of HO-1+/− BM cells. (A) Leukocyte counts of HO-1+/− mice after myelotoxic injury. HO-1+/− or HO-1+/+ mice (n = 10) were treated with a single dose of 5-FU (150 mg/kg intraperitoneally), and leukocyte counts in the peripheral blood were performed at different time points after treatment and are shown as a mean (± SD) percentage of normal leukocyte count. (B,C) Hematopoietic engraftment from HO-1–deficient BM cells in lethally irradiated recipients. BM cells (5 × 106) from luc+HO-1+/− or luc+HO-1+/+ mice were transferred into lethally irradiated recipients (n = 4) and hematopoietic engraftment was monitored by BLI. Representative BLI images of the recipients of luc+HO-1+/− or luc+HO-1+/+ cells at day 18 are displayed at the same scale (B). Time course of hematopoietic reconstitution, as measured by whole-body bioluminescent intensity (mean ± SD, photons/s) over time (C). (D) Representative FACS plots and (E) relative trend of CFSE+LinSca-1+ cell distribution versus number of cell division in vivo. Nucleated BM cells (1 × 107) from either HO-1+/− or HO-1+/+ mice were labeled by CFSE (1 μM) and transferred into lethally irradiated recipients. Cells recovered from the BM of the recipients 48 hours after transfer were pooled (3 mice/group) and costained by antibodies against lineage markers and Sca-1. The number of cell divisions and cell distribution were analyzed by CFSE intensity after gating for the LinSca-1+ population. Values are absolute (D) or relative (E) mean percentages (n = 4) of cells undergoing different numbers of cell divisions from 2 different experiments.

Close Modal

or Create an Account

Close Modal
Close Modal